Ausgabe 2/2022
Inhalt (8 Artikel)
Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer
Xiaojia Li, Jie He, Keping Xie
How VEGF-A and its splice variants affect breast cancer development – clinical implications
Hivin Al Kawas, Inas Saaid, Paul Jank, Christina C. Westhoff, Carsten Denkert, Therese Pross, Karoline Barbara Stephanie Weiler, Maria Margarete Karsten
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
Marcell Costa de Medeiros, Min Liu, Rajat Banerjee, Emily Bellile, Nisha J. D’Silva, Carlos Rossa Jr
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer
Francesca De Santis, Sandra L. Romero-Cordoba, Lorenzo Castagnoli, Tatiana Volpari, Simona Faraci, Giovanni Fucà, Elda Tagliabue, Filippo De Braud, Serenella M. Pupa, Massimo Di Nicola
Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway
Jungwhoi Lee, Jungsul Lee, Woogwang Sim, Jae-Hoon Kim
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer
Ning Zhang, Yifeng Liao, Weize Lv, Shunda Zhu, Yeqing Qiu, Nan Chen, Mei Xiao, Hongyu Zhang
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells
Yao Chen, Xiaoqin Lu, Ling Gao, Douglas C. Dean, Yongqing Liu
PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer
Laura Boyero, Joel Martin-Padron, María Esther Fárez-Vidal, Maria Isabel Rodriguez, Álvaro Andrades, Paola Peinado, Alberto M. Arenas, Félix Ritoré-Salazar, Juan Carlos Alvarez-Perez, Marta Cuadros, Pedro P. Medina